Adverum Biotechnologies, Inc.

NasdaqCM:ADVM 주식 보고서

시가총액: US$125.6m

Adverum Biotechnologies 관리

관리 기준 확인 3/4

Adverum Biotechnologies CEO는 Laurent Fischer, Jun2020 에 임명되었습니다 의 임기는 4.42 년입니다. 총 연간 보상은 $ 1.55M, 43.4% 로 구성됩니다. 43.4% 급여 및 56.6% 보너스(회사 주식 및 옵션 포함). 는 $ 425.30K 가치에 해당하는 회사 주식의 0.34% 직접 소유합니다. 425.30K. 경영진과 이사회의 평균 재임 기간은 각각 2.8 년과 4.5 년입니다.

주요 정보

Laurent Fischer

최고 경영자

US$1.5m

총 보상

CEO 급여 비율43.4%
CEO 임기4.4yrs
CEO 소유권0.3%
경영진 평균 재임 기간2.8yrs
이사회 평균 재임 기간4.5yrs

최근 관리 업데이트

Recent updates

Adverum: Ixo-Vec Could Reduce Treatment Burden For Wet-AMD Patients

Nov 18

We're Keeping An Eye On Adverum Biotechnologies' (NASDAQ:ADVM) Cash Burn Rate

Feb 24
We're Keeping An Eye On Adverum Biotechnologies' (NASDAQ:ADVM) Cash Burn Rate

We Think Adverum Biotechnologies (NASDAQ:ADVM) Needs To Drive Business Growth Carefully

Sep 07
We Think Adverum Biotechnologies (NASDAQ:ADVM) Needs To Drive Business Growth Carefully

Adverum Biotechnologies GAAP EPS of -$0.44 misses by $0.10

Aug 11

Adverum gains 13% to reach three-month high after Truist upgrade

Jul 07

We Think Adverum Biotechnologies (NASDAQ:ADVM) Needs To Drive Business Growth Carefully

May 12
We Think Adverum Biotechnologies (NASDAQ:ADVM) Needs To Drive Business Growth Carefully

We're Not Very Worried About Adverum Biotechnologies' (NASDAQ:ADVM) Cash Burn Rate

Jul 17
We're Not Very Worried About Adverum Biotechnologies' (NASDAQ:ADVM) Cash Burn Rate

Adverum Biotechnologies: An Uncertain Path Forward

May 05

Adverum Bio presents long-term data from ADVM-022 trial in wet AMD

May 03

We're Not Very Worried About Adverum Biotechnologies' (NASDAQ:ADVM) Cash Burn Rate

Apr 06
We're Not Very Worried About Adverum Biotechnologies' (NASDAQ:ADVM) Cash Burn Rate

Don't Ignore The Fact That This Insider Just Sold Some Shares In Adverum Biotechnologies, Inc. (NASDAQ:ADVM)

Feb 13
Don't Ignore The Fact That This Insider Just Sold Some Shares In Adverum Biotechnologies, Inc. (NASDAQ:ADVM)

Adverum highlights preclinical long-term safety data on ADVM-022 IVT gene therapy

Feb 02

Trade Alert: The Independent Chairman Of Adverum Biotechnologies, Inc. (NASDAQ:ADVM), C. Machado, Has Just Spent US$115k Buying 15% More Shares

Jan 22
Trade Alert: The Independent Chairman Of Adverum Biotechnologies, Inc. (NASDAQ:ADVM), C. Machado, Has Just Spent US$115k Buying 15% More Shares

Adverum In Wet AMD And Diabetic Macular Edema: Playing In A Differentiated Market

Jan 11

Adverum Biotechnologies announces new GMP gene therapy manufacturing facility

Jan 07

How Much Are Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Insiders Spending On Buying Shares?

Dec 31
How Much Are Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Insiders Spending On Buying Shares?

CEO 보상 분석

Laurent Fischer 의 보수는 Adverum Biotechnologies 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

-US$94m

Jun 30 2024n/an/a

-US$100m

Mar 31 2024n/an/a

-US$113m

Dec 31 2023US$2mUS$672k

-US$117m

Sep 30 2023n/an/a

-US$126m

Jun 30 2023n/an/a

-US$133m

Mar 31 2023n/an/a

-US$146m

Dec 31 2022US$3mUS$646k

-US$155m

Sep 30 2022n/an/a

-US$156m

Jun 30 2022n/an/a

-US$154m

Mar 31 2022n/an/a

-US$155m

Dec 31 2021US$9mUS$621k

-US$146m

Sep 30 2021n/an/a

-US$149m

Jun 30 2021n/an/a

-US$138m

Mar 31 2021n/an/a

-US$123m

Dec 31 2020US$22mUS$327k

-US$118m

보상 대 시장: Laurent 의 총 보상 ($USD 1.55M )은 US 시장( $USD 649.63K ).

보상과 수익: Laurent 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Laurent Fischer (60 yo)

4.4yrs

테뉴어

US$1,546,477

보상

Dr. Laurent Fischer, M.D., serves as Chair of the Board of Teal Omics Inc. He has been the Independent Supervisory Director of Atai Life Science N.V. since May 2024. He is Advisor of FORM Life Ventures. He...

리더십 팀

이름위치테뉴어보상소유권
Laurent Fischer
President4.4yrsUS$1.55m0.34%
$ 425.3k
Linda Rubinstein
CFO, Principal Financial Officer & Principal Accounting Officer1.9yrsUS$2.30m0.048%
$ 60.4k
Kishor Soparkar
Chief Operating Officer3.4yrsUS$903.02k0.13%
$ 167.9k
Setareh Seyedkazemi
Chief Development Officer2.8yrsUS$799.36k0.026%
$ 32.4k
Rabia Ozden
Chief Medical Officerless than a yearUS$94.20k0%
$ 0
R. Ramelmeier
Chief Technology Officer1.3yrs데이터 없음데이터 없음
Romuald Corbau
Chief Scientific Officerless than a year데이터 없음데이터 없음
John Rakow
Senior VP & General Counsel3.3yrsUS$1.33m0.031%
$ 39.1k
Dena House
Chief People Officer5.3yrs데이터 없음데이터 없음
Carla Fiankan
Senior Vice President of Regulatory Affairs2.8yrs데이터 없음데이터 없음
Michael Steel
Senior Vice President of Quality3.1yrs데이터 없음데이터 없음
Heikki Jouttijarvi
Senior VP of Manufacturing & Supply Chain Management and Head of Technical Operationsno data데이터 없음데이터 없음

2.8yrs

평균 재임 기간

56.5yo

평균 연령

경험이 풍부한 관리: ADVM 의 관리팀은 경험 ( 2.8 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Laurent Fischer
President4.4yrsUS$1.55m0.34%
$ 425.3k
James Scopa
Independent Director5.5yrsUS$111.70k0.050%
$ 62.4k
Scott Whitcup
Independent Director4.6yrsUS$106.70k0%
$ 0
David Boyer
Scientific Advisory Board Memberno data데이터 없음데이터 없음
C. Machado
Independent Chairman7.7yrsUS$163.80k0.042%
$ 53.3k
Jeffrey Heier
Scientific Advisory Board Memberno data데이터 없음데이터 없음
Reed Tuckson
Independent Director3.8yrsUS$99.20k0%
$ 0
Dawn Svoronos
Independent Director3.9yrsUS$106.70k0.024%
$ 30.2k
Mark Lupher
Independent Director5.5yrsUS$99.20k0.062%
$ 78.5k
Charles Wykoff
Scientific Advisory Board Memberno data데이터 없음데이터 없음
Arshad Khanani
Scientific Advisory Board Memberno data데이터 없음데이터 없음
Szilard Kiss
Directorless than a year데이터 없음데이터 없음

4.5yrs

평균 재임 기간

63yo

평균 연령

경험이 풍부한 이사회: ADVM 의 이사회는 경험(평균 재직 기간 4.5 년)으로 간주됩니다.